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Multidomain proteins of the extracellular matrix (ECM) play an important role in development and maintenance of 
cellular organization and in tissue repair. Several ECM proteins such as laminin, tenascinand thrombospondin contain 
domains with homology to epidermal growth factor (EGF) and exhibit growth promoting activity. The mitogenic activity 
of laminin is restricted to a fragment which consists of about 25 repeating domains with partial homology to EGF and 
comprises the rod-like inner regions of the three short arms of the four armed molecule. The mitogenic activity does 
not correlate with promotion of cell attachment and neurite outgrowth for which major functional sites have been found 
in other regions of the laminin molecule. It is suggested that EGF-like domains in laminin, in other ECM proteins and 
in the extracellular portions of some membrane proteins are signals for cellular growth and differentiation. Because they 
are integral parts of large molecules and often of supramolecular assemblies these domains are well suited to stimulate 
neighboring cells in a specific and vectorial way. This concept of localixed growth or differentiation signals offers an at- 
tractive mechanism for the regulation of cellular development. 
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1. INTRODUCTION 
Much is known about small diffusible growth 
factors, their binding to specific cellular receptors 
and the mechanisms of transmembrane signalling. 
The complex cascade of intracellular events which 
leads to growth, proliferation and differentiation 
is being explored in conjunction with the 
fascinating field of oncogenes and anti-oncogenes. 
Less is known about the spatial organization of 
growth factors in tissues. Concentration gradients 
are important and for some growth factors binding 
to large components of the extracellular matrix like 
proteoglycans appears to be essential [I]. In addi- 
tion domains with growth factor activity which are 
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integral parts of the extracellular matrix may 
stimulate target cells in a much more selective way 
than diffusible growth factors. 
Domains with a close or distant homology with 
epidermal growth factor (EGF), transforming 
growth factor- (TGF-(Y) and vaccinia growth fac- 
tor (VGF) have been found in multidomain pro- 
teins of the extracellular matrix (ECM) including 
laminin [2], tenascin [3] and thrombospondin [4]. 
The latter proteins play an important role in 
cellular development and tissue repair. Before 
reviewing their structure and the limited evidence 
that some of these domains express mitogenic ac- 
tivity, some relevant data on EGF and TGF-a and 
their precursor forms should be recalled. 
EGF, TGFcv AND THEIR PRECURSORS 
The potent growth factors EGF and TGF-cz [6,7] 
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are small proteins (53 and 50 residues) of 
homologous sequences and conformations which 
were recently elucidated by NMR [7-91. The pro- 
teins consist of two distinct subdomains with only 
few contacts between them (fig.1). The larger one 
comprises residues 1 to 32 and is stabilized by two 
disulfide bridges. The small one (residues 33-48) is 
stabilized by a single disulfide bond. In the C- 
terminal small domain the peptide chain is folded 
very tightly into an S-shaped structure with two 
short stretches of antiparallel &structure. This 
unusual conformation is only possible when a 
number of residues including Cys 33, Gly 39 and 
Cys 42 (fig.1) and the distances between them are 
well conserved. This explains why different EGF- 
like sequences even if otherwise rather different are 
very homologous in the C-terminal region [lo]. 
The large domain consists of two rather open loops 
and a third large loop with a prominent an- 
tiparallel &structure. Here conformational se- 
quence requirements are relaxed and loops of 
rather variable size may be accommodated without 
changing the basic core structure. Accordingly, 
distances between Cys residues and other features 
of the sequence are less conserved in the N- 
terminal than in the C-terminal region [lo]. 
The native structure of EGF is stabilized by 
disulfide bridges and reductive cleavage causes loss 
of function [5,11]. Within the loops many residues 
are not essential for conformational stability and 
can be freely altered to serve different functions. 
Progress has been made to define residues which 
are functionally important by site-directed 
mutagenesis [12] and by comparison of peptides 
[lo, 1 l] but the latter approach suffers from the 
large dependence of function on structural in- 
tegrity. 
Both EGF and TGF-cu are derived by processing 
from much larger precursor molecules, which in 
addition to the domains corresponding to the small 
diffusible growth factors contain several other 
EGF-like domains and some unrelated domains of 
unknown function [13,14]. The sequences of all 
known precursors of growth factors which act via 
the EGF-receptor [ 151 contain a putative mem- 
brane spanning domain. Recently it was shown 
[14,14a] that the TGF-a precursor is indeed a 
transmembrane glycoprotein that can mediate cell- 
to-cell stimulation by binding to the EGF receptor. 
Whether only the domain with the sequence of 
2 
processed TGF-a or additional domains are in- 
volved is not known. In any case the results 
highlight the point that domains of large proteins 
rather than only small diffusible growth factors 
can be active in cellular stimulation. Internaliza- 
tion of the ligand-receptor complex [ 151 is pro- 
bably not possible for membrane bound proteins 
and for large ECM components but the results 
with TGF-(r precursor indicate that it is not essen- 
tial for the initial steps of cellular stimulation. 
2. PROTEINS OF THE EXTRACELLULAR 
MATRIX AND CELLULAR 
DEVELOPMENT 
The important role of ECM components in 
development and maintenance of cellular 
organization and in tissue repair has been increas- 
ingly recognized in the past decade. Multidomain 
glycoproteins of the ECM [2,16,17] are similarly 
important in morphogenesis as the membrane 
bound cell attachment molecules (CAMS) [18]. As 
for the CAMS, focal expression at distinct stages of 
organ development is observed for many ECM 
proteins. Well studied examples are fibronectin 
[19,20], tenascin (also referred to as cytotactin, 
hexabrachion, Jl) [3,21] and laminin [2,16]. Each 
of the three proteins exhibits diverse functions. On 
the one hand they are structural components of 
specialized forms of the ECM but on the other 
hand the existence of organ specific isoforms and 
splicing variants indicates that these proteins also 
possess specific biological activities. For example 
laminin is the first ECM component which is 
detected at the two cell stage in the mouse embryo 
[22]. It is later found as an ubiquitous component 
of basement membranes and at this stage it 
mediates cell attachment [2,16]. A homolog of 
laminin (s-laminin) is found with high abundance 
in the synaptic cleft of the neuromuscular junction 
[23]. This is of significance since laminin is a po- 
tent promoter of neurite outgrowth [24]. 
There are numerous other cellular functions 
which have been ascribed to laminin and other 
ECM proteins [2,16,25]. This diversity is reflected 
by the large number of cellular receptors which 
have been found. The exploration of receptors 
specific for ECM proteins started only some years 
ago and is expanding at a very high rate. Members 
of the large family of integrin receptors [26] ac- 
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quire their specificity for individual ECM proteins 
by the variable combination of a few ,& with a 
large number of a-subunits. Some of them 
recognize arginine-glycine-aspartate (RGD) motifs 
found in ECM proteins but there are also receptors 
of this and other types which are not ‘RGD depen- 
dent’ [27]. Integrin receptors are currently looked 
at as mechanical mediators between ECM and 
cytoskeleton and so far second messenger genera- 
tion by them has not been observed. In contrast to 
EGF-receptor [ 151 or other growth factor receptors 
the cytosolic domains of integrins are small and do 
not resemble a tyrosine kinase. On the other hand, 
phosphorylation of an integrin in the cytosolic part 
of its P-domain by oncogenic EGF-receptor 
homologs has been demonstrated [28] suggesting a
communication between integrins and growth fac- 
tor receptors. 
3. EGF-LIKE DOMAINS IN ECM PROTEINS 
AND THEIR MITOGENIC FUNCTION 
Large proteins of the extracellular matrix such 
as laminin, tenascin and thrombospondin consist 
of structurally and often functionally autonomous 
domains which often occur as modular units in 
several different ECM proteins. Small Cys-rich do- 
mains of distant or close homology with EGF are 
frequent elements. They are present in the above 
mentioned examples and are also found in other 
proteins [lo]. 
molecules exhibit only a much lower degree of con- 
servation. As compared to EGF the Cys-rich 
repeats in laminin are somewhat larger and contain 
8 instead of 6 Cys residues (fig.1). The mode of 
disulfide linkage is not known but it may be ten- 
tatively assumed that the first six Cys residues are 
linked as in EGF [5] and in factor X [36]. The con- 
nection between the 7th and 8th Cys would then 
add an extra loop to the laminin repeats which is 
not present in EGF (fig.1). Strong sequence 
homology with EGF and TGF-cu is restricted to a 
region around the 5th and 6th Cys which cor- 
responds to the small domain in EGF. There are 9 
identities and 2 conservative replacements in 14 
residues if TGF-a is compared with one of the 
repeats in the Bl chain of laminin (figs 1 and 2). 
Structurally important residues are also preserved 
in the other EGF-like repeats in laminin. Much less 
homology is observed between the laminin repeats 
and EGF in the region of the large domain of EGF. 
In particular, the first two cysteines of the laminin 
repeats are separated by a single residue whereas in 
the EGF structure they are linked by a flexible loop 
of seven residues (fig.1). These Cys residues are 
however in close proximity in the 3D-structure and 
the loop can indeed be replaced by a single residue. 
These and other features render it likely that also 
the N-terminal segments of the laminin repeats 
which are not clearly homologous with EGF have 
an EGF-like conformation (fig. 1). 
In most cases EGF-like sequence regions are 
repeated manyfold in rod-like and accessible 
regions of the molecules. Laminin (900 kDa) has a 
cruciform structure with three short and one long 
arm composed of rod-like and globular elements 
[2,29]. The sequence of the three constituent 
polypeptide chains: Bl , B2 (about 220 kDa) and A 
(about 450 kDa) have been elucidated for mouse 
[30], and in part for human [31-331 and 
Drosophila laminin [34,35]. From sequence data 
and electron microscopic evidence [29] it follows 
that the rod-like regions in the three short arms are 
composed of altogether about 40 EGF-like subdo- 
mains which are arranged like beads on a string in 
groups of 3 to 9 repeating units (fig.2). 
Tenascin is a six-armed molecule (fig.2) and 
each of the arms contains an uninterrupted array 
of 13 EGF-like repeats with strong homology to 
EGF [37]. Similar to laminin these arrays con- 
stitute rod-like regions of the arms. The translation 
per EGF-like repeat is 2 nm in tenascin and 2.5 nm 
in laminin as determined by electron microscopy. 
These values may be compared with the distance 
between N- and C-termini for EGF of about 2 nm 
[7,8]. Another protein in which EGF-like domains 
form part of a rod-like region is thrombospondin 
(420 kDa), a large glycoprotein found in platelet 
granules and in the ECM of the vascular wall [38]. 
Three repeats with strong homology to EGF have 
been found in each of the three arms of this 
molecule (fig.2). 
The EGF-like domains in laminin exhibit strong Interestingly promotion of cell growth is ob- 
internal homology. They are well conserved served for all three proteins. For thrombospondin, 
(average identity 60%) between mammalian and autocrine growth supportive action on smooth 
Drosophila laminins whereas other regions of the muscle cells is synergistic with EGF and other 
3 
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Fig. 1. (a) Schematic representation of the 3D-structure of EGF 
and TGFa as determined by NMR for an active derivative 
(residues l-48) of human EGF [7] and mouse EGF [8]. A very 
similar structure is suggested for TGF-(r by an NMR 
determination of its secondary structure [9]. (b) The 
hypothetical structure of one of the 40 ‘EGF-like’ units in 
laminin (4th repeat in region III of the Bl chain, see fig.2). The 
sequences of mouse EGF (top sequence of a), rat TGF-(u 
(bottom sequence of a, numbering for mouse EGF) [5] and of 
the laminin domain [30] are indicated by the one letter code. 
Residues which are highly conserved in EGF and TGF-(r of 
different species are represented by bold characters and 
disulfide bridges by thick bars. The dashed line indicates the 
boundary between the large N-terminal and small C-terminal 
domain [7,8]. 
growth factors [39]. Chick embryo fibroblasts and 
various tumor cells continue to divide in the 
absence of serum when grown on a tenascin 
substrate [40]. Promotion of growth is also 
reported in several studies in which cultured cells 
are grown on laminin substrates [25]. From such 
studies in which laminin (or another ECM protein) 
is used as a substrate and cells are grown in a 
medium containing fetal calf serum, indirect ef- 
fects of cell attachment on growth cannot be ex- 
cluded. As discussed by Kleinman et al. [25] 
receptors for growth factors present in the medium 
may become more accessible by substrate induced 
Fig.2. Schematic drawings of (a) laminin [29,30], (b) nidogen 
[2,42], (c) tenascin [3,21,37] and (d) thrombospondin [4,38] 
with EGF-like domains indicated by circles. For other details of 
the complex domain organization of the molecules see the 
above cited references. The EGF-like laminin domain whose 
sequence and predicted structure is shown in fig.lb is marked 
by an asterisk and that in nidogen which contains the RGD 
sequence by an arrow. Localization of fragments 1, 4 and 8 in 
the laminin molecules which were used in mitogenic and cell 
attachment studies (table 1) are indicated by numbers. Amino 
termini of the three chains are indicated by their designations A, 
Bl and B2. The three molecules are drawn approximately to 
scale. 
changes of cell shape. In a recent study [41], this 
problem was circumvented by the use of quiescent 
cells attached to plastic and by addition of laminin 
and fragments thereof in soluble form to a medium 
containing very low serum levels. Cell attachment 
and mitogenic activities have been measured 
separately for a number of fragments derived from 
different regions of the laminin molecule acting on 
a variety of cultured cells and the following results 
were obtained: the mitogenic response of cells to 
laminin and to its fragment 1 is comparable to that 
of EGF concerning effective concentration, mag- 
nitude, time dependence and synergetic enhance- 
ment by insulin. Laminin exhibits mitogenic 
activity on all cells studied except on NR6 cells 
which lack the EGF receptor. The activity is 
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localized in fragment 1 which comprises the inner 
short arm structures of laminin and consists of 
about 25 EGF-like repeats (fig.2). Fragments 
originating from other parts of the molecules ex- 
hibit no growth factor activity but are in part ac- 
tive in cell attachment (table 1). There is no 
correlation between mitogenic and cell attachment 
activity which are therefore two distinct functions 
of the laminin molecule presumably mediated by 
different receptors. 
Laminin is often non-covalently associated with 
a 150 kDa protein referred to as nidogen, entactin 
or C-chain [2]. Nidogen (fig.2) also contains EGF- 
like domains [42] and binds tightly to the inner 
rod-like segments of laminin. The laminin-nidogen 
complex was therefore also tested for mitogenic 
function [41] and was found to be as active as 
laminin. Isolated nidogen, however, had no 
growth factor activity on the cells which were 
tested [41]. Interestingly one of its EGF-like do- 
mains contains an RGD sequence (fig.2) and it has 
been proposed that this sequence is recognized by 
an integrin receptor in the RGD dependent cell at- 
tachment on nidogen [43]. 
The cellular receptor involved in the growth 
stimulation by laminin has so far not been iden- 
tified. The close resemblance of the dose response, 
the synergism with insulin, the activation of S6 
kinase by fragment 1 and the lack of response of 
EGF receptor deficient NR6 cells could indicate 
that mitogenic mechanisms of laminin and EGF 
proceed in some steps via related pathways. On the 
other hand, laminin and its active fragments do 
not compete with EGF for binding to cells [41]. It 
is unlikely that the EGF-like regions in laminin are 
processed into small diffusible growth factors by 
cells because fragment 1 is the proteolytically least 
sensitive region in the molecule [2,16]. I favor the 
concept of a mitogenic stimulation of cells by un- 
processed domains in analogy with TGF-(r precur- 
sor and Notch (see below). The mitogenically 
active domain 1 may be accessible to cells only dur- 
ing early stages of tissue development before 
laminin is assembled into an intact basement mem- 
brane and may become exposed again after 
damage of basement membranes by injury. Under 
these conditions, laminin may express its growth 
factor-like function on neighbouring cells and may 
also act on the cells that secrete it by autocrine 
stimulation. Laminin domain 1 has been localized 
Table 1 
Mitogenic and cell attachment activities (in parentheses) of 
laminin (L) and its fragments 1,8 and 4 according to Panayotou 
et al. [41] 
Cell line L 1 8 4 
Swiss 3T3 + (+) + (+) - (+) - 
BALB/c + (+) + (-) - (+) nd 
PAM 212 + (-) + (-) -(-) - 
MCF-7 nd 
NR6 -;+, -1+, -“p+) nd 
Swiss 3T3 and BALB/c are fibroblastoid cell lines, NR6 is a 
Swiss 3T3 variant cell line of different clomd origin devoid of 
EGF receptor, PAM 212 are mouse epidermal cells and MCF-7 
human breast carcinoma cells. nd, not determined 
in the interior of epithelial cornea1 basement mem- 
brane [44] and renal tubular basement membrane 
[45] of adult mice and is thus very unlikely to be 
in direct contact with the surface of epithelial cells 
being attached to the basement membrane. Such 
cells are normally arrested in a nonproliferative 
phase. This indicates an advantage of growth pro- 
moting activity being present in a large structural 
protein allowing a localized and regulated action 
when compared with a diffusible small growth fac- 
tor that would exert its action in a much less con- 
trolled fashion. 
4. ARE GENERALIZATIONS POSSIBLE? 
For ECM proteins other than laminin conclusive 
data which would allow to attribute their 
mitogenic function to their domains containing 
EGF-like repeats are still missing. Even for laminin 
the function has only been localized in a relatively 
large fragment which in addition to its many EGF- 
like repeats may contain small portions of other 
domains (fig.2). The possibility that EGF-like do- 
mains in laminin are involved in mitogenic func- 
tion may however be related to the proposed 
functions of repeated arrays of EGF-like units in 
Notch and lin-12 (reviewed in 1461). Both proteins 
regulate the development of certain cell lineages. A 
point mutation in one of the 35 EGF-like repeats 
of Notch has a dramatic effect on this function. As 
for laminin the possibility that diffusible EGF-like 
peptides are released by processing of the ex- 
tracellular domain of Notch was discussed, but 
5 
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available evidence [46] suggests that the cellular in- 
teractions are due to unprocessed extracellular do- 
mains containing the EGF-like repeats. 
It is tempting to speculate that EGF-like growth 
factors and related domains in multidomain pro- 
teins have evolved from a common ancestor with 
the original function of providing signals in 
cellular communication. This function may have 
diversified into different signals for growth, dif- 
ferentiation, and other receptor mediated func- 
tions. The best known members of this family, 
EGF and TGF-(r, are very important in embryonic 
development and this is also suggested for the sta- 
tionary EGF-like domains in a number of ex- 
tracellular multidomain proteins. Examples for 
functions apparently not related to growth or dif- 
ferentiation are the recognition of an EGF-like do- 
main in urokinase-type plasminogen activator by 
its receptor [lo] and the hypothetical role of EGF- 
like domains in LDL-receptor and related proteins 
[47]. The long arrays of EGF-like domains in many 
proteins were probably formed by gene duplica- 
tion. A functional advantage could be the creation 
of multiple-binding sites, which may be important 
for the oligomerization of receptors or for more 
specific recognition. Oligomerization of the EGF 
receptor is considered to be essential for 
transmembrane signalling [48]. ECM proteins and 
extracellular domains of membrane bound pro- 
teins mediate between rather distant sites of ECM 
components and cells. The insertion of spacer 
elements between functional domains may 
therefore provide another evolutionary advantage. 
Many of the EGF-like domains in ECM proteins 
may therefore have lost their original specific func- 
tion and may now only serve as structural spacer 
elements in rod-like regions of the molecules. This 
may also hold true for the many other proteins of 
apparently unrelated function and structure which 
contain EGF-like domains. It is interesting to note, 
however, that the list of specific receptor-mediated 
functions reported for EGF-like regions in these 
proteins is increasing [10,471. Almost every month 
a new gene locus with important functions in 
Drosophila development is described which en- 
codes for proteins with EGF-like domains. 
Homologs of the EGF receptor have also been 
found ([49] and references therein). It is therefore 
a reasonable working hypothesis that not all of the 
many EGF-like domains in ECM proteins are dull 
6 
spacer units but that some of them have very in- 
teresting and specific functions. 
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